Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick M Sexton

Showing results (121-130 of 301) with videos related to

Pageof 31
Sort By:
Molecular Pharmacology|February 18, 2010
H2 relaxin is a biased ligand relative to H3 relaxin at the relaxin family peptide receptor 3 (RXFP3)Emma T van der Westhuizen, Arthur Christopoulos, Patrick M Sexton, et al.
Plos One|May 11, 2018
Comparative genotypic and phenotypic analysis of human peripheral blood monocytes and surrogate monocyte-like cell lines commonly used in metabolic disease researchDarren M Riddy, Emily Goy, Philippe Delerive, et al.
Molecular Pharmacology|May 28, 2011
Polymorphism and ligand dependent changes in human glucagon-like peptide-1 receptor (GLP-1R) function: allosteric rescue of loss of function mutationCassandra Koole, Denise Wootten, John Simms, et al.
The Journal of Biological Chemistry|December 8, 2011
Second extracellular loop of human glucagon-like peptide-1 receptor (GLP-1R) differentially regulates orthosteric but not allosteric agonist binding and functionCassandra Koole, Denise Wootten, John Simms, et al.
Molecular Pharmacology|March 8, 2024
Development of a Novel Assay for Direct Assessment of Selective Amylin Receptor Activation Reveals Novel Differences in Behavior of Selective and Nonselective Peptide AgonistsPeter Keov, George Christopoulos, Caroline A Hick, et al.
Molecular Pharmacology|June 16, 2010
Delineating the mode of action of adenosine A1 receptor allosteric modulatorsCeline Valant, Luigi Aurelio, Vijay B Urmaliya, et al.
Biochemical Pharmacology|September 10, 2018
Glucagon-like peptide-1 receptor internalisation controls spatiotemporal signalling mediated by biased agonistsMadeleine M Fletcher, Michelle L Halls, Peishen Zhao, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 16, 2010
Modulation of the glucagon-like peptide-1 receptor signaling by naturally occurring and synthetic flavonoidsDenise Wootten, John Simms, Cassandra Koole, et al.
Molecular Pharmacology|May 10, 2008
Spatial approximation between secretin residue five and the third extracellular loop of its receptor provides new insight into the molecular basis of natural agonist bindingMaoqing Dong, Polo C-H Lam, Delia I Pinon, et al.
The Journal of Biological Chemistry|September 11, 2007
Fluorescence resonance energy transfer analysis of secretin docking to its receptor: mapping distances between residues distributed throughout the ligand pharmacophore and distinct receptor residuesKaleeckal G Harikumar, Polo C-H Lam, Maoqing Dong, et al.
Pageof 31

Showing results (121-130 of 301) with videos related to

Sort By:
Pageof 31
Molecular Pharmacology|February 18, 2010
H2 relaxin is a biased ligand relative to H3 relaxin at the relaxin family peptide receptor 3 (RXFP3)Emma T van der Westhuizen, Arthur Christopoulos, Patrick M Sexton, et al.
Plos One|May 11, 2018
Comparative genotypic and phenotypic analysis of human peripheral blood monocytes and surrogate monocyte-like cell lines commonly used in metabolic disease researchDarren M Riddy, Emily Goy, Philippe Delerive, et al.
Molecular Pharmacology|May 28, 2011
Polymorphism and ligand dependent changes in human glucagon-like peptide-1 receptor (GLP-1R) function: allosteric rescue of loss of function mutationCassandra Koole, Denise Wootten, John Simms, et al.
The Journal of Biological Chemistry|December 8, 2011
Second extracellular loop of human glucagon-like peptide-1 receptor (GLP-1R) differentially regulates orthosteric but not allosteric agonist binding and functionCassandra Koole, Denise Wootten, John Simms, et al.
Molecular Pharmacology|March 8, 2024
Development of a Novel Assay for Direct Assessment of Selective Amylin Receptor Activation Reveals Novel Differences in Behavior of Selective and Nonselective Peptide AgonistsPeter Keov, George Christopoulos, Caroline A Hick, et al.
Molecular Pharmacology|June 16, 2010
Delineating the mode of action of adenosine A1 receptor allosteric modulatorsCeline Valant, Luigi Aurelio, Vijay B Urmaliya, et al.
Biochemical Pharmacology|September 10, 2018
Glucagon-like peptide-1 receptor internalisation controls spatiotemporal signalling mediated by biased agonistsMadeleine M Fletcher, Michelle L Halls, Peishen Zhao, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 16, 2010
Modulation of the glucagon-like peptide-1 receptor signaling by naturally occurring and synthetic flavonoidsDenise Wootten, John Simms, Cassandra Koole, et al.
Molecular Pharmacology|May 10, 2008
Spatial approximation between secretin residue five and the third extracellular loop of its receptor provides new insight into the molecular basis of natural agonist bindingMaoqing Dong, Polo C-H Lam, Delia I Pinon, et al.
The Journal of Biological Chemistry|September 11, 2007
Fluorescence resonance energy transfer analysis of secretin docking to its receptor: mapping distances between residues distributed throughout the ligand pharmacophore and distinct receptor residuesKaleeckal G Harikumar, Polo C-H Lam, Maoqing Dong, et al.
Pageof 31